Kate Birchall will be responsible for clearing house LCH’s business in Asia-Pacific, including the CCP’s existing OTC derivatives clearing operations in Sydney and Tokyo, according to a statement.
She joins LCH from NAB, where she was most recently head of portfolio optimisation and collateral. Prior to that, she was a director at KPMG and has also held various roles at Lloyds, CIBC and ANZ.
LCH chief executive Martin Pluves said he’s pleased to welcome Ms Birchall to the LCH team.
“She brings with her substantial experience of the markets in Australia and internationally, and will be an asset to our leadership team,” Mr Pluves said.
“In her new role she will oversee our growing business in Asia-Pacific, fostering relationships with market participants in the region, and leading our colleagues based in Australia and Japan.”
